managing myelofibrosis-associated anemia
Published 1 month ago • 11 plays • Length 4:00Download video MP4
Download video MP3
Similar videos
-
1:58
novel myelofibrosis-associated anemia treatments in phase ii trials
-
4:30
managing myelofibrosis-associated thrombocytopenia
-
1:49
approved and emerging agents to manage anemia and thrombocytopenia in myelofibrosis
-
2:42
the management of moderate to severe anemia in patients with myelofibrosis
-
1:38
phase ii trial of luspatercept in myelofibrosis-associated anemia
-
4:49
when and how do we manage anemia in myelofibrosis?
-
10:42
treatment of primary myelofibrosis
-
1:30
addressing unmet needs in myelofibrosis: alleviating anemia
-
1:53
sotatercept in patients with mpn-associated myelofibrosis and anemia
-
24:31
managing myelofibrosis in 2021 - dr. srdan verstovsek
-
3:20
safety and anemia outcomes with momelotinib vs pacritinib in patients with myelofibrosis
-
2:08
a study exploring sotatercept and ruxolitinib in mpn-associated myelofibrosis and anemia
-
2:10
management of ruxolitinib failure in myelofibrosis
-
49:35
thursday webinars - primary myelofibrosis: diagnosis and treatment
-
4:49
myelofibrosis - causes, symptoms, diagnosis, treatment, pathology
-
3:30
limber-104: zilurgisertib /- ruxolitinib in patients with mf-associated anemia
-
6:10
how does anemia impact overall survival in myelofibrosis?
-
1:57
challenges in myelofibrosis management
-
2:43
managing myelofibrosis complications